<code id='9319E2B938'></code><style id='9319E2B938'></style>
    • <acronym id='9319E2B938'></acronym>
      <center id='9319E2B938'><center id='9319E2B938'><tfoot id='9319E2B938'></tfoot></center><abbr id='9319E2B938'><dir id='9319E2B938'><tfoot id='9319E2B938'></tfoot><noframes id='9319E2B938'>

    • <optgroup id='9319E2B938'><strike id='9319E2B938'><sup id='9319E2B938'></sup></strike><code id='9319E2B938'></code></optgroup>
        1. <b id='9319E2B938'><label id='9319E2B938'><select id='9319E2B938'><dt id='9319E2B938'><span id='9319E2B938'></span></dt></select></label></b><u id='9319E2B938'></u>
          <i id='9319E2B938'><strike id='9319E2B938'><tt id='9319E2B938'><pre id='9319E2B938'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:2
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          UnitedHealth, Optum discontinue NaviHealth name
          UnitedHealth, Optum discontinue NaviHealth name

          MarkLennihan/APUnitedHealthGroupandOptumaregettingridofthenameoftheirtech-drivencaremanagementcompan

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          AstraZeneca to buy developer of next

          AlastairGrant/APLONDON—AstraZenecasaidTuesdayitwouldacquireFusionPharmaceuticalsinadealworthmorethan